Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Basosquamous carcinoma
ADR ID BADD_A00431
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.16      Miscellaneous and site unspecified neoplasms malignant and unspecified
16.16.01      Neoplasms malignant site unspecified NEC
16.16.01.012      Basosquamous carcinoma
Description A skin carcinoma that histologically exhibits both basal and squamous elements. (From Dorland, 27th ed) [MeSH]
MedDRA Code 10004178
MeSH ID D002281
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Basal squamous cell carcinoma | Basi squamous cell carcinoma | Basosquamous carcinoma | Carcinoma basosquamous | Carcinoma, Basosquamous | Basosquamous Carcinoma | Basosquamous Carcinomas | Carcinomas, Basosquamous
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00047Afatinib0.000112%
BADD_D00424Cevimeline--
BADD_D00425Cevimeline hydrochloride--
BADD_D02344Vemurafenib0.000112%
The 1th Page    1    Total 1 Pages